Видео с ютуба Nirogacestat

#ESMO22 Highlights on nirogacestat in patients with progressing desmoid tumours: The DeFi study

Nirogacestat success for desmoid tumours

Nirogacestat emerges as a treatment for desmoid tumor: 2022 ESMO Florida

Nirogacestat’s Mechanism of Action to Treat Desmoid Tumors

DeFi trial: nirogacestat vs placebo for patients with progressing desmoid tumors

Результаты клинического исследования нирогацестата DeFi у пациентов с десмоидными опухолями

Nirogacestat improves outcomes for people with sarcoma, shows phase 3 clinical trial

DeFi: nirogacestat demonstrates improved PFS and ORR in progressing desmoid tumors

New medical therapies in Desmoid Tumor: Nirogacestat - Palassini, MD

Nirogacestat Being Evaluated for Desmoid Tumors in Adults and Children

Comparing surveillance and surgery for the management of desmoid tumors

NCODA's Nirogacestat: Treatment Support Kit

Доктор А.С. Элиза Ф. Нассиф Хаддад | Прецизионная онкология при саркоме

Нирогацестат усиливает экспрессию BCMA и улучшает результаты лечения. Малин Хульткранц, доктор ме...

Treatment Options for Desmoid Tumors, Including Nirogacestat in Children

Nirogacestat (Ogsiveo) – What You Need to Know | Medication Guide

Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressi...

Knowledge Spot Webinar: Gamma Secretase Inhibitors - A new paradigm in Desmoid Tumors?

Desmoid Tumors and the Approval of Ogsiveo